Lorazepam effects on word memory test performance: A randomized, double-blind, placebo-controlled, crossover trial

Clinical Neuropsychologist

Volumn 25, Issue 5, 2011, Pages 799-811

  Loring, David W ^a   Marino, Susan E ^b   Drane, Daniel L ^a   Parfitt, David ^c   Finney, Glen R ^c   Meador, Kimford J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Assessment; Benzodiazepine; Malingering; Symptom validity testing

Indexed keywords

BENZODIAZEPINE RECEPTOR AFFECTING AGENT; LORAZEPAM;

ADOLESCENT; ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LINGUISTICS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; RANDOMIZED CONTROLLED TRIAL; REACTION TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GABA MODULATORS; HUMANS; LORAZEPAM; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; VOCABULARY; YOUNG ADULT;

EID: 79960683115     PISSN: 13854046     EISSN: 17444144     Source Type: Journal    
DOI: 10.1080/13854046.2011.583279     Document Type: Article

References (43)

1. Begg, C., Cho, M., Eastwood, S., Horton, R., Moher, D., Olkin, I., et al. (1996). Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 276(8), 637-639. (Pubitemid 26278070)
2. Brandt, J. (1991). The Hopkins Verbal Learning Test: Development of a new verbal memory est with six equivalent forms. The Clinical Neuropsychologist, 5, 125-142.
3. Brown, L., Sherbenou, R. J., & Johnsen, S. K. (1996). Test of Non-verbal Intelligence (3rd ed., TONI-3). Austin, TX: Pro-Ed.
4. Cragar, D. E., Berry, D. T., Fakhoury, T. A., Cibula, J. E., & Schmitt, F. A. (2006). Performance of patients with epilepsy or psychogenic non-epileptic seizures on four measures of effort. The Clinical Neuropsychologist, 20(3), 552-566. (Pubitemid 44221707)
5. Donders, J., & Boonstra, T. (2007). Correlates of invalid neuropsychological test performance after traumatic brain injury. Brain Injury, 21(3), 319-326. (Pubitemid 46567426)
6. Drane, D. L. (in press). Neuropsychological evaluation of the epilepsy surgery candidate. In C. Morrison & W. B. Barr (Eds.), Handbook of the neuropsychology of epilepsy. New York, NY: Springer.
7. Drane, D. L., Williamson, D. J., Stroup, E. S., Holmes, M. D., Jung, M., Koerner, E., et al. (2006). Cognitive impairment is not equal in patients with epileptic and psychogenic nonepileptic seizures. Epilepsia, 47(11), 1879-1886. (Pubitemid 44730058)
8. Ellis, P. (2010). The essential guide to effect sizes: Statistical power, meta-analysis, and the interpretation of research results. New York, NY: Cambridge University Press.
9. Flaro, L., Green, P., & Robertson, E. (2007). Word Memory Test failure 23 times higher in mild brain injury than in parents seeking custody: The power of external incentives. Brain Injury, 21(4), 373-383. (Pubitemid 46767354)
10. Frederick, R. I., & Bowden, S. C (2009). The test validation summary. Assessment, 16(3), 215-236.
11. Green, P. (2003). Green's Word Memory Test: User's manual. Edmonton, Canada: Green's Publishing Inc.
12. Green, P. (2005). Green's Word Memory Test for Windows User's manual-revised. Edmonton, Canada: Green's Publishing.
13. Greve, K. W., Ord, J., Curtis, K. L., Bianchini, K. J., & Brennan, A. (2008). Detecting malingering in traumatic brain injury and chronic pain: A comparison of three forced-choice symptom validity tests. The Clinical Neuropsychologist, 22(5), 896-918.
14. Gross, R. A., & Johnston, K. C. (2009). Levels of evidence: Taking Neurology® to the next level. Neurology, 72(1), 8-10.
15. Gualtieri, C. T., & Johnson, L. G (2006a). Antidepressant side effects in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 16(1-2), 147-157.
16. Gualtieri, C. T., & Johnson, L. G (2006b). Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Archives of Clinical Neuropsychology, 21(7), 623-643. (Pubitemid 44754740)
17. Heilbronner, R. L., Sweet, J. J., Morgan, J. E., Larrabee, G J., & Millis, S. R. (2009). American Academy of Clinical Neuropsychology Consensus Conference Statement on the neuropsychological assessment of effort, response bias, and malingering. The Clinical Neuropsychologist, 23(7), 1093-1129.
18. Henry, M., Merten, T., Wolf, S. A., & Harth, S. (2010). Nonverbal Medical Symptom Validity Test performance of elderly healthy adults and clinical neurology patients. Journal of Clinical and Experimental Neuropsychology, 32(1), 19-27.
19. Holtzer, R., Goldin, Y., Zimmerman, M., Katz, M., Buschke, H., & Lipton, R. B. (2008). Robust norms for selected neuropsychological tests in older adults. Archives of Clinical Neuropsychology, 23(5), 531-541.
20. Howard, M. E., Jackson, M. L., Kennedy, G A., Swann, P., Barnes, M., & Pierce, R. J. (2007). The interactive effects of extended wakefulness and low-dose alcohol on simulated driving and vigilance. Sleep, 30(10), 1334-1340. (Pubitemid 47548284)
21. Howe, L. L., & Loring, D. W. (2009). Classification accuracy and predictive ability of the medical symptom validity test's dementia profile and general memory impairment profile. The Clinical Neuropsychologist, 23(2), 329-342.
22. Larrabee, G J. (Ed.). (2005). Forensic neuropsychology: A scientific approach. New York, NY: Oxford University Press.
23. Larrabee, G J., Greiffenstein, M. F., Greve, K. W., & Bianchini, K. J. (2007). Refining diagnostic criteria for malingering. In G J. Larrabee (Ed.), Assessment of malingered neuropsychological deficits. New York, NY: Oxford University Press.
24. Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological Assessment (4th ed.). New York, NY: Oxford University Press.
25. Loring, D. W., & Bowden, S. C. (2011). Developing evidence based neuropsychology practice: More than a flicker of hope using STROBE. Manuscript submitted for publication.
26. Loring, D. W., Lee, G. P., & Meador, K. J. (2005). Victoria Symptom Validity Test performance in non-litigating epilepsy surgery candidates. Journal of Clinical & Experimental Neuropsychology, 27(5), 610-617. (Pubitemid 40896474)
27. Loring, D. W., Meador, K. J., Lee, G. P., & King, D. W. (1992). Amobarbital effects and lateralized brain function: The Wada Test. New York, NY: Springer-Verlag.
28. Martins, M., & Martins, I. P. (2010). Memory malingering: Evaluating WMT criteria. Applied Neuropsychology, 17(3), 177-182.
29. Meehl, P. E., & Hathaway, S. R. (1946). The K factor as a suppressor variable in the Minnesota Multiphasic Personality Inventory. Journal of Applied Psychology, 30(5), 525-564.
30. Meehl, P. E., & Rosen, A. (1967). Antecedent probability and the efficiency of psychometric signs, patterns, on cutting scores. In D. N. Jackson & S. Messick (Eds.), Problems in human assessment. New York: McGraw-Hill.
31. Meyers, J. E., & Volbrecht, M. E. (2003). A validation of multiple malingering detection methods in a large clinical sample. Archives of Clinical Neuropsychology, 18(3), 261-276. (Pubitemid 36369366)
32. Mills, K. C., Spruill, S. E., Walker, J. M., & Lamson, M. (2009). A clinical trial demonstration of a web-based test for alcohol and drug effects. Journal of Studies on Alcohol and Drugs, 70(2), 308-313.
33. Post, R. B., Chaderjian, M. R., Maddock, R. J., & Lott, L. A. (1997). Effects of lorazepam on the distribution of spatial attention. Experimental and Clinical Psychopharmacology, 5(2), 143-149. (Pubitemid 27239816)
34. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
35. Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340(340), c332.
36. Sharland, M. J., & Gfeller, J. D. (2007). A survey of neuropsychologists' beliefs and practices with respect to the assessment of effort. Archives of Clinical Neuropsychology, 22(2), 213-223. (Pubitemid 46371364)
37. Slick, D. J., Sherman, E. M., & Iverson, G. L. (1999). Diagnostic criteria for malingered neurocognitive dysfunction: proposed standards for clinical practice and research. The Clinical Neuropsychologist, 13(4), 545-561. (Pubitemid 30311324)
38. Subhan, Z., Harrison, C., & Hindmarch, I. (1986). Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep. European Journal of Clinical Pharmacology, 29(6), 709-712. (Pubitemid 16155745)
39. Sweet, J. J. (1999a). Malingering: Differential diagnosis. In J. J. Sweet (Ed.), Forensic neuropsychology: Fundamentals and practice. Exton, PA: Swets & Zeitlinger.
40. Sweet, J. J. (Ed.). (1999b). Forensic neuropsychology: Fundamentals and practice. Exton, PA: Swets & Zeitlinger.
41. Verster, J. C., Wester, A. E., Goorden, M., van Wieringen, J. P., Olivier, B., & Volkerts, E. R. (2009). Novice drivers' performance after different alcohol dosages and placebo in the divided-attention steering simulator (DASS). Psychopharmacology (Berl), 204(1), 127-133.
42. Williamson, D. J., Drane, D. L., & Stroup, E. S. (2007). Symptom validity tests in the epilepsy clinic. In K. B. Boone (Ed.), Assessment of feigned cognitive impairment. New York, NY: Guilford Publications.
43. Willis, B. H. (2008). Spectrum bias-why clinicians need to be cautious when applying diagnostic test studies. Family Practice, 25(5), 390-396.